BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 17570328)

  • 1. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
    Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
    Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of in vitro tumor cell proliferation by cytokines induced by combinations of TLR or TLR and TCR agonists.
    Ghosh TK; Mickelson DJ; Lipson KE; Alkan SS
    Int Immunopharmacol; 2007 Nov; 7(11):1471-82. PubMed ID: 17761351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages.
    Franchini M; Schweizer M; Mätzener P; Magkouras I; Sauter KS; Mirkovitch J; Peterhans E; Jungi TW
    Vet Immunol Immunopathol; 2006 Mar; 110(1-2):37-49. PubMed ID: 16216336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D; Zepp F; Meyer CU
    Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.
    Ramakers BP; Riksen NP; Rongen GA; van der Hoeven JG; Smits P; Pickkers P
    Cytokine; 2006 Jul; 35(1-2):95-9. PubMed ID: 16963274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
    McDonald DR; Brown D; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells.
    Motegi A; Kinoshita M; Sato K; Shinomiya N; Ono S; Nonoyama S; Hiraide H; Seki S
    J Leukoc Biol; 2006 Mar; 79(3):463-72. PubMed ID: 16387840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
    Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
    Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors.
    Weaver LK; Pioli PA; Wardwell K; Vogel SN; Guyre PM
    J Leukoc Biol; 2007 Mar; 81(3):663-71. PubMed ID: 17164428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity.
    Lauzon NM; Mian F; MacKenzie R; Ashkar AA
    Cell Immunol; 2006 Jun; 241(2):102-12. PubMed ID: 17049504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
    Remer KA; Brcic M; Sauter KS; Jungi TW
    J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
    Roelofs MF; Wenink MH; Brentano F; Abdollahi-Roodsaz S; Oppers-Walgreen B; Barrera P; van Riel PL; Joosten LA; Kyburz D; van den Berg WB; Radstake TR
    Ann Rheum Dis; 2009 Sep; 68(9):1486-93. PubMed ID: 18765427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of Toll-like receptors in chicken heterophils.
    Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
    Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.